Table 3. Summary of plasma levels of Aβ40, Aβ42 measured at either 2 or 3 time points, respectively for transgenic (Tg) mice given either control or Vitamin D mushroom (VDM) feeds.
Measure | Time-mo | Tg-control | Tg-VDM |
Aβ40 (pM) | 2 | 441.4±33.7 (a) | 463.2±40.8 (a) |
9 | 636.9±21.4 (b) | 641.2±40.3 (b) | |
Aβ42 (pM) | 2 | 165.4±10.6 (c) | 153.6±12.2 (c) |
5 | 165.6±17.4 (c) | 158.9±16.1 (c) | |
9 | 197.0±9.1 (d) | 185.0±17.2 (d) |
Results are the mean and SEM of 7–12 mice per treatment group.
(a, b) Two-way repeat measure ANOVA showed significant difference from 2 to 9 months (P<0.05) for Aβ40 and for Aβ42, between 2 months and both 5 and 9 months (c, d, P<0.05).